JUN 02, 2021 7:30 AM PDT

Industry Response to the Expanding Need in Immuno-Oncology for Validated Antibodies

Speaker

Abstract

Identifying reliable antibodies for use in immuno-oncology research is critical to address its recent growth and rapid expansion into clinical trials as mistakes in antibody validation impact patient health and wellbeing.  In this session, Dr. McWilliams discusses important validation considerations to make in your work to help ensure antibodies are on-target and performing as expected.  Unique challenges to antibody validation will be presented, providing a framework for why careful validation is needed and why collaboration between manufacturers and researchers is the best solution.  Recent publications and specific types of experiments will be explored to demonstrate how these experiments can best be applied to antibody validation and what to expect from the manufacturer of your antibodies.

Learning Objectives:

1. Understand the significance of antibody validation, including its needs and challenges

2. Gain insight into the antibody industry validation approach and learn steps to validate antibodies in your lab

3. How a collaborative approach to validation between researchers and manufacturers presents the best opportunity for long-term solutions


Show Resources
You May Also Like
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
C.E. CREDITS
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with multiple motor and non-motor symptoms. PD is characterized by the presence on proteinaceous neuronal...
Loading Comments...
Show Resources